News
PRAH
--
0.00%
--
ICON Announces Pricing of Senior Secured Notes
ICON plc (NASDAQ: ICLR) ("ICON") announced today in connection with the proposed acquisition by ICON of PRA Health Sciences, Inc. ("PRA") pursuant to which Indigo Merger Sub, Inc., a wholly owned subsidiary of ICON ("Merger Sub") will merge with and into P...
Business Wire · 4d ago
ICON Shareholders Vote in Favour of All Resolutions at its Extraordinary General Meeting
ICON plc (NASDAQ: ICLR) ("ICON"), a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations, today announced that all resolutio...
Business Wire · 5d ago
PRA Health Sciences, Inc.'s (NASDAQ:PRAH) Stock Is Going Strong: Is the Market Following Fundamentals?
Most readers would already be aware that PRA Health Sciences' (NASDAQ:PRAH) stock increased significantly by 14% over...
Simply Wall St. · 6d ago
ICON's Indigo Merger Sub to raise $2.515B through private debt offering
In connection with the proposed acquisition by ICON ([[ICLR]] -0.5%) of PRA Health Sciences (PRAH) pursuant to which Indigo Merger Sub, Inc., a wholly owned subsidiary will merge with and
Seekingalpha · 06/14 15:45
ICON Announces Private Offering of Senior Secured Notes
ICON plc (NASDAQ: ICLR) ("ICON") announced today in connection with the proposed acquisition by ICON of PRA Health Sciences, Inc. ("PRA") pursuant to which Indigo Merger Sub, Inc., a wholly owned subsidiary of ICON ("Merger Sub") will merge with and into P...
Business Wire · 06/14 11:59
Correction: Mizuho Securities Maintains Price Target for PRA Health Sciences at $169, Reiterates Neutral Rating
MT Newswires · 06/07 16:38
--Mizuho Securities Adjusts PRA Health Sciences PT to $155 From $169, Maintains Neutral Rating
MT Newswires · 06/07 12:28
Here's Why You Should Retain PRA Health (PRAH) Stock for Now
Zacks.com · 06/01 13:08
Anavex Life Sciences Announces Appointment of Ms Jiong Ma, PhD to Board of Directors
Strengthening Board of Directors with Expertise in Innovative Product Launches
GlobeNewswire · 05/26 12:09
S&P 500 Stock Diagnoses Breakout After Buying Spree, 455% Growth
Investor's Business Daily · 05/26 12:05
The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 25)
Benzinga · 05/26 11:33
Stocks That Hit 52-Week Highs On Tuesday
    Tuesday's morning session saw 173 companies set new 52-week highs.
Benzinga · 05/25 14:52
The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24)
Benzinga · 05/25 11:53
The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20)
Benzinga · 05/21 11:26
Stocks That Hit 52-Week Highs On Thursday
    Before 10 a.m. ET Thursday, 56 stocks made new 52-week highs.
Benzinga · 05/20 14:27
Bioanalytical Testing Services Market Size to Reach USD 4.33 Billion in 2028 | Revenue, Industry Statistics, Share, Analysis and Global Research Report by Emergen Research
The global bioanalytical testing services market size is expected to reach USD 4.33 Billion in 2028 and register a steady CAGR during the forecast period, according to latest analysis by Emergen Research. Factors such as rising focus on analytical testing ...
GlobeNewswire · 05/19 01:00
Cnh Partners Llc Buys Cantel Medical Corp, Coherent Inc, FLIR Systems Inc, Sells Eidos ...
GuruFocus News · 05/18 23:38
The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17)
Benzinga · 05/18 11:44
PRA Health's (PRAH) New Solution to Speed Up Drug Development
Zacks.com · 05/17 13:14
PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma
Pharmaceutical, biotech and other research sponsors can now connect their clinical studies to longitudinal real-world data - speeding up drug development and aligning with the 21st Century Cures Act.
Globe Newswire · 05/13 20:02
Webull provides a variety of real-time PRAH stock news. You can receive the latest news about PRA Health through multiple platforms. This information may help you make smarter investment decisions.
About PRAH
PRA Health Sciences, Inc. is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. Its services include data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. It provides its clients with clinical development service offerings, which includes both traditional, project-based Phase I through Phase IV services, as well as embedded and functional outsourcing services. As of December 31, 2016, its clinical development platform included approximately 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East. The Company's service offerings include product registration, strategic solutions and early development services.